Pressmeddelande

Prolight‘s CEO to BioStock: “Roche’s acquisition highlights interest in Point-of-Care”

Cision Publicerad: 29 Jan 09:05

There is a high demand within healthcare for Point-of-Care systems. The field also attracts significant interest from leading diagnostics companies. This was recently demonstrated by Roche’s acquisition of LumiraDx’s Point-of-Care technology for USD 295 million. Ulf Bladin, CEO of Swedish POC company Prolight Diagnostics, comments on the acquisition and shares the company’s partnership ambitions in an interview with BioStock.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/01/prolights-ceo-roches-acquisition-highlights-interest-in-point-of-care/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Prolight Diagnostics

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!